{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Board Pearls","title":"Chapter 26, Ep 1 of 5: Chronic Pancreatitis Framework and Pain","html":"","width":"100%","height":180,"duration":978,"description":"Episode one of the Chronic Pancreatitis, Cysts, and Neoplasms chapter builds the framework from a single fact: fewer than three percent of heavy drinkers ever develop the disease, so exposure alone is never enough and a co-modifier has to do the converting. The organizing idea is that tobacco and a genetic background decide who progresses, and where each gene sits in the trypsin-control pathway sets its inheritance, penetrance, and cancer risk. Diagnosis is calibrated to stage, CT for calcification, secretin-MRCP for the duct, endoscopic ultrasound for minimal-change parenchyma, and function testing for the gland that still looks normal. Pain is worked in steps, from cessation and non-opioid analgesics through neuromodulators to decompression, with the randomized shift that moved early surgery ahead of endoscopy the tested pivot. Cause, mechanism, staging, and steps throughout.\n \nTopics covered\n\nFibroinflammatory disease and the co-modifier concept\nTobacco and genetic background as converters\nTIGAR-O etiologic classification\nGenetic forms and trypsin regulation\nCationic trypsinogen cancer risk and surveillance\nStaged diagnosis: CT, secretin-MRCP, endoscopic ultrasound\nFunctional testing for early disease\nStepwise pain management\nEarly surgery in dilated-duct disease\n \n \nKey decisions\n\nFewer than three percent of heavy alcohol users develop chronic pancreatitis, so a toxic exposure needs a co-modifier, usually tobacco plus a genetic background, before fibrosis takes hold.\nA patient over fifty with a first idiopathic acute pancreatitis episode needs cross-sectional imaging follow-up once inflammation settles, because obstruction from pancreatic adenocarcinoma is the must-not-miss of the obstructive category.\nCationic trypsinogen gain-of-function disease carries the highest cancer risk of any subset, earning routine surveillance with annual MRI alternating with endoscopic ultrasound starting at age forty.\nGenetic testing is indicated when the cause is unclear, when...","thumbnail_url":"https://img.transistorcdn.com/-FuAdDBcPDLhEoUmroZKtOBRvuBn_FHPpYlh41hOnU4/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iNzlh/ZTU4Y2MzNWExMjQ5/MjA5OWMwMmI3ZTk5/NGFiZS5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}